Our [4] and others’ results [5,7,8,20,21] indicate that TGF-β acts as a tumor promoter in the progressive stages of cancers to support tumor cell motility, survival, invasion, metastasis, and immune evasion. The gene discussed is TGFB1; the disease is neoplasm.